Discovery-Corp Enterprises
CVE:DCYDiscovery-Corp Enterprises Inc., an exploration stage company, explores for base and precious metals in Canada. The company focuses on gold and copper properties. It holds a 100% interest in the Galaxy property comprising seven mineral claims and two crown-granted mineral claims covering an area of 91 hectares located in the Kamloops Mining Division of British Columbia, Canada. It also holds an undivided 50% interest in the mineral rights associated with Rock Creek Ranch property located in Humboldt County, Nevada, the United States. The company was formerly known as Getchell Resources Incorporated and changed its name to Discovery-Corp Enterprises Inc. in 2000. Discovery-Corp Enterprises Inc. was incorporated in 1986 and is headquartered in Vancouver, Canada.
Meritage Homes
NYSE:MTHMeritage Homes Corporation, together with its subsidiaries, designs and builds single-family attached and detached homes in the United States. The company operates through two segments, Homebuilding and Financial Services. It acquires and develops land; and constructs, markets, and sells homes for entry-level and first move-up buyers in Arizona, California, Colorado, Utah, Texas, Florida, Georgia, North Carolina, South Carolina, and Tennessee. The company also offers title and escrow, mortgage, insurance, and closing/settlement services to its homebuyers. Meritage Homes Corporation was founded in 1985 and is based in Scottsdale, Arizona.
Psyence Biomedical
NASDAQ:PBMPsyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.
Weingarten Realty Investors
NYSE:WRIWeingarten Realty Investors (NYSE: WRI) is a shopping center owner, manager and developer. At September 30, 2020, the Company owned or operated under long-term leases, either directly or through its interest in real estate joint ventures or partnerships, a total of 162 properties which are located in 15 states spanning the country from coast to coast. These properties represent approximately 31.0 million square feet of which our interests in these properties aggregated approximately 21.0 million square feet of leasable area.